| scholarly article | Q13442814 |
| P50 | author | Markus Dold | Q40783423 |
| Alessandro Serretti | Q56380923 | ||
| Lucie Bartova | Q60674326 | ||
| P2093 | author name string | S Kasper | |
| J Zohar | |||
| S Montgomery | |||
| S Porcelli | |||
| D Souery | |||
| J Mendlewicz | |||
| P2860 | cites work | Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis | Q22242068 |
| A rating scale for depression | Q24564540 | ||
| A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report | Q28261272 | ||
| The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 | ||
| A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
| Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice | Q29614979 | ||
| Medication augmentation after the failure of SSRIs for depression. | Q33994373 | ||
| Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. | Q34088016 | ||
| National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 | ||
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision | Q34865036 | ||
| Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials | Q34997918 | ||
| Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review | Q36114397 | ||
| Antidepressant drug use among adolescents during 2004-2013: a population-based register linkage study. | Q37394533 | ||
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders | Q38123516 | ||
| History, background, concepts and current use of comedication and polypharmacy in psychiatry. | Q38138638 | ||
| Role of lithium augmentation in the management of major depressive disorder | Q38192967 | ||
| A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression | Q38234664 | ||
| Antipsychotic Medication Treatment Patterns in Adult Depression. | Q38689268 | ||
| Evidence-based pharmacotherapy of treatment-resistant unipolar depression | Q39009865 | ||
| Switching the Antidepressant After Nonresponse in Adults With Major Depression: A Systematic Literature Search and Meta-Analysis | Q39120346 | ||
| Geographical disparities in prescription practices of lithium and clozapine: a community-based study | Q40041318 | ||
| Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials | Q41016132 | ||
| Suicide risk in patients treated with lithium | Q44121101 | ||
| Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression | Q47769498 | ||
| Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials. | Q47770326 | ||
| A randomized clinical trial comparing two two-phase treatment strategies for in-patients with severe depression | Q47882077 | ||
| Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder | Q48506440 | ||
| Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program | Q48831169 | ||
| Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. | Q48878233 | ||
| Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. | Q53091817 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 401-412 | |
| P577 | publication date | 2018-02-28 | |
| P1433 | published in | Acta Psychiatrica Scandinavica | Q4033348 |
| P1476 | title | Clinical correlates of augmentation/combination treatment strategies in major depressive disorder. | |
| P478 | volume | 137 |
Search more.